Carboplatin Treatment for Head and Neck Cancer
Author Information
Author(s): Bertino Giulia, Benazzo Marco, Gatti Patrizia, Bernardo Gianni, Corbella Franco, Tinelli Carmine, Zappoli Federico, Mira Eugenio
Primary Institution: University of Pavia – IRCCS Policlinico S Matteo, Pavia, Italy
Hypothesis
Is intra-arterial carboplatin induction chemotherapy a feasible and effective treatment for advanced head and neck cancer?
Conclusion
Intra-arterial carboplatin induction chemotherapy is a safe and well-tolerated technique that can help identify responders and non-responders, which may guide further treatment.
Supporting Evidence
- No severe toxicity was reported in the study.
- 83% of patients achieved a complete response after treatment.
- 39% of patients were alive and disease-free after five years.
Takeaway
This study shows that giving a special type of chemotherapy directly to the tumor can help some patients with head and neck cancer get better without major side effects.
Methodology
Patients received 3 cycles of intra-arterial carboplatin followed by surgery or radiotherapy, with evaluations of response and survival.
Potential Biases
Potential selection bias due to the non-randomized nature of the study.
Limitations
The study is limited to a single center and a relatively small sample size.
Participant Demographics
46 patients (43 men and 3 women), aged 39 to 75 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website